ELAVL2 and cancer: In accordance with the previous results, the graphical summary of IPA demonstrated that cancer and inflammatory-associated biological functions, including invasion of tumor and interaction of leukocytes, as well as critical cancer-related genes such as CD44, TNF, and IL-1B, are markedly deactivated in ELAVL2-high GBM patients (Fig. 4a).